Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HIMS
|
Patrick Harrison Carroll
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 23,287 Reduced 10.0% |
$798,976
$34.31 p/Share
|
Mar 18
2025 |
|
SRE
|
Peter R Wall
SVP, Controller and CAO |
SELL
Open market or private sale
|
Direct | 8,192 Reduced 40.84% |
$580,075
$70.81 p/Share
|
Mar 18
2025 |
|
CW
|
John C Watts
Vice President Strat & Bus Dev |
SELL
Open market or private sale
|
Direct | 228 Reduced 4.04% |
$74,193
$325.41 p/Share
|
Mar 18
2025 |
|
CW
|
George P. Mc Donald
VP and Corporate Secretary |
SELL
Open market or private sale
|
Direct | 148 Reduced 7.23% |
$48,160
$325.41 p/Share
|
Mar 18
2025 |
|
CW
|
Paul J Ferdenzi |
SELL
Open market or private sale
|
Direct | 658 Reduced 3.31% |
$214,297
$325.68 p/Share
|
Mar 18
2025 |
|
CW
|
Lynn M Bamford
Chair and CEO |
SELL
Open market or private sale
|
Direct | 3,131 Reduced 6.8% |
$1,018,858
$325.41 p/Share
|
Mar 18
2025 |
|
CW
|
K Christopher Farkas
Vice President and CFO |
SELL
Open market or private sale
|
Direct | 922 Reduced 6.17% |
$300,083
$325.47 p/Share
|
Mar 18
2025 |
|
CW
|
Kevin Rayment
Vice President and COO |
SELL
Open market or private sale
|
Direct | 1,003 Reduced 3.73% |
$326,707
$325.73 p/Share
|
Mar 18
2025 |
|
CW
|
Robert F Freda
Vice President and Treasurer |
SELL
Open market or private sale
|
Direct | 136 Reduced 2.74% |
$44,262
$325.46 p/Share
|
Mar 18
2025 |
|
CW
|
Gary A Ogilby
VP & Corporate Controller |
SELL
Open market or private sale
|
Direct | 200 Reduced 7.22% |
$65,072
$325.36 p/Share
|
Mar 18
2025 |
|
EPR
|
Mark Alan Peterson
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 13,700 Reduced 0.0% |
$709,249
$51.77 p/Share
|
Mar 18
2025 |
|
PCYG
|
Randall K Fields
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$96,000
$19.2 p/Share
|
Mar 18
2025 |
|
GSAT
|
James Monroe Iii
Director |
BUY
Open market or private purchase
|
Indirect | 25,000 Added 0.0% |
$520,000
$20.8 p/Share
|
Mar 18
2025 |
|
JOBY
|
Didier Papadopoulos
President of Aircraft OEM |
SELL
Open market or private sale
|
Direct | 3,710 Reduced 5.41% |
$23,261
$6.27 p/Share
|
Mar 18
2025 |
|
AFG
|
John I Von Lehman |
SELL
Open market or private sale
|
Direct | 2,542 Reduced 18.66% |
$319,453
$125.67 p/Share
|
Mar 18
2025 |
|
CTRA
|
Adam M Vela
SVP & General Counsel |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 7.34% |
$230,160
$28.77 p/Share
|
Mar 18
2025 |
|
VRSK
|
Lee Shavel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,100 Reduced 1.73% |
$318,076
$289.16 p/Share
|
Mar 18
2025 |
|
AKAM
|
Paul C Joseph
EVP - Global Sales |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 9.7% |
$333,480
$83.37 p/Share
|
Mar 18
2025 |
|
ECC
|
Kenneth P. Onorio
CFO/COO |
BUY
Open market or private purchase
|
Direct | 6,250 Added 7.61% |
$50,000
$8.0 p/Share
|
Mar 18
2025 |
|
MKZR
|
Christine Elizabeth Simpson
Chief Portfolio Manager |
BUY
Open market or private purchase
|
Direct | 1,000 Added 33.33% |
$1,780
$1.78 p/Share
|
Mar 18
2025 |
|
CNO
|
Gary C Bhojwani
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 27,918 Reduced 8.39% |
$1,144,079
$40.98 p/Share
|
Mar 18
2025 |
|
CYTK
|
Fady Ibraham Malik
EVP Research & Development |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.4% |
$87,160
$43.58 p/Share
|
Mar 18
2025 |
|
ZVIA
|
Amy Taylor
President & CEO |
SELL
Open market or private sale
|
Direct | 29,079 Reduced 1.89% |
$60,775
$2.09 p/Share
|
Mar 18
2025 |
|
ZVIA
|
Lorna R. Simms
SVP, GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct | 4,957 Reduced 2.26% |
$10,409
$2.1 p/Share
|
Mar 18
2025 |
|
CBKM
|
David R Bickerton
Director |
BUY
Open market or private purchase
|
Direct | 500 Added 16.67% |
$9,530
$19.06 p/Share
|
Mar 18
2025 |
|
CION
|
Eric A. Pinero
Chief Legal Officer |
BUY
Open market or private purchase
|
Direct | 465 Added 4.85% |
$4,984
$10.72 p/Share
|
Mar 18
2025 |
|
KEQU
|
Keith M Gehl
Director |
BUY
Open market or private purchase
|
Direct | 403 Added 2.32% |
$19,747
$49.0 p/Share
|
Mar 18
2025 |
|
KIDS
|
David R Bailey
President and CEO |
SELL
Open market or private sale
|
Direct | 6,620 Reduced 2.03% |
$164,573
$24.86 p/Share
|
Mar 18
2025 |
|
KIDS
|
Daniel J Gerritzen
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 5,310 Reduced 4.57% |
$132,006
$24.86 p/Share
|
Mar 18
2025 |
|
KIDS
|
Fred Hite
COO and CFO |
SELL
Open market or private sale
|
Direct | 6,443 Reduced 3.0% |
$160,172
$24.86 p/Share
|
Mar 18
2025 |
|
KIDS
|
Joseph W Hauser
Pres. Trauma & Def. Correction |
SELL
Open market or private sale
|
Direct | 5,300 Reduced 3.71% |
$131,758
$24.86 p/Share
|
Mar 18
2025 |
|
KIDS
|
Gregory A Odle
President of Scoliosis |
SELL
Open market or private sale
|
Direct | 5,359 Reduced 3.48% |
$133,224
$24.86 p/Share
|
Mar 18
2025 |
|
NBBK
|
Paul A Evangelista
EVP, Dir Spec. Bank. Ctr. |
BUY
Open market or private purchase
|
Direct | 500 Added 2.12% |
$9,370
$18.74 p/Share
|
Mar 18
2025 |
|
ALTR
|
Ravi Kunju
Chief Product Strategy Officer |
SELL
Open market or private sale
|
Direct | 229 Reduced 0.66% |
$25,487
$111.3 p/Share
|
Mar 17
2025 |
|
ARQT
|
Todd Franklin Watanabe
Director |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 0.13% |
$21,132
$17.61 p/Share
|
Mar 17
2025 |
|
ZOM
|
Rodney James Williams |
BUY
Open market or private purchase
|
Direct | 100,000 Added 27.63% |
$7,000
$0.07 p/Share
|
Mar 17
2025 |
|
MDXG
|
Kimberly Maersk Moller
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 1,759 Reduced 0.57% |
$14,142
$8.04 p/Share
|
Mar 17
2025 |
|
RIOT
|
Douglas Mouton |
BUY
Open market or private purchase
|
Direct | 8,384 Added 29.14% |
$64,892
$7.74 p/Share
|
Mar 17
2025 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 792 Reduced 1.09% |
$117,057
$147.8 p/Share
|
Mar 17
2025 |
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 6,702 Reduced 3.19% |
$978,693
$146.03 p/Share
|
Mar 17
2025 |
|
EVCM
|
Matthew David Feierstein
President |
SELL
Open market or private sale
|
Direct | 8,963 Reduced 0.37% |
$89,809
$10.02 p/Share
|
Mar 17
2025 |
|
NTRA
|
John Fesko
PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct | 795 Reduced 0.5% |
$117,501
$147.8 p/Share
|
Mar 17
2025 |
|
NTRA
|
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct | 1,026 Reduced 0.7% |
$151,735
$147.89 p/Share
|
Mar 17
2025 |
|
NTRA
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 928 Reduced 0.41% |
$137,241
$147.89 p/Share
|
Mar 17
2025 |
|
NTRA
|
Matthew Rabinowitz
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 1,127 Reduced 0.05% |
$166,570
$147.8 p/Share
|
Mar 17
2025 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct | 181 Reduced 0.07% |
$26,431
$146.03 p/Share
|
Mar 17
2025 |
|
TMCI
|
Sean F. Scanlan
Chief Innovation Officer |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 12.07% |
$398,500
$7.97 p/Share
|
Mar 17
2025 |
|
ACMR
|
Chenming Hu |
SELL
Open market or private sale
|
Direct | 163,308 Reduced 62.02% |
$4,899,240
$30.0 p/Share
|
Mar 17
2025 |
|
MP
|
James H. Litinsky
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 489,918 Reduced 0.0% |
$13,115,104
$26.77 p/Share
|
Mar 17
2025 |
|
CPNG
|
Benjamin Sun
Director |
SELL
Open market or private sale
|
Indirect | 250,000 Reduced 0.0% |
$5,792,500
$23.17 p/Share
|
Mar 17
2025 |